Back
CenterPoint Energy Vs. Keros Therapeutics Industry Stock Comparison
Buy
60
CNP
CenterPoint Energy
Last Price:
29.80
Seasonality Move:
2.13%
Buy
68
KROS
Keros Therapeutics
Last Price:
59.23
Seasonality Move:
45.94%
Buy
60
CenterPoint Energy (CNP)
is a Buy
Is CenterPoint Energy a Buy, Sell or Hold?
- The current CenterPoint Energy [CNP] share price is $29.79. The Score for CNP is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- CNP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $59.33. The Score for KROS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNP Stock Price Chart
What is CenterPoint Energy's stock price today?
-
The CenterPoint Energy share price today is $29.79
The current trend is moderately bullish and CNP is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $59.33
The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
CNP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 58.12 | Buy |
| Chaikin Money Flow: | -4828850 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.71 - 30.09) | Buy |
| Bollinger Bands (100): | (27.22 - 30.46) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.74 | Buy |
| Relative Strength Index (14 RSI): | 54.42 | Buy |
| Chaikin Money Flow: | -73900 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.33 - 60.71) | Buy |
| Bollinger Bands (100): | (44.91 - 56.17) | Buy |
CNP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.86 | Sell |
| 20-day SMA: | 29.65 | Buy |
| 50-day SMA: | 28.18 | Buy |
| 200-day SMA: | 28.6 | Buy |
| 8-day EMA: | 29.89 | Sell |
| 20-day EMA: | 29.53 | Buy |
| 50-day EMA: | 28.88 | Buy |
| 200-day EMA: | 28.66 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.18 | Sell |
| 20-day SMA: | 59.23 | Buy |
| 50-day SMA: | 53.7 | Buy |
| 200-day SMA: | 54.65 | Buy |
| 8-day EMA: | 60.13 | Sell |
| 20-day EMA: | 58.89 | Buy |
| 50-day EMA: | 55.53 | Buy |
| 200-day EMA: | 51.4 | Buy |
CenterPoint Energy Earnings Growth & CNP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.11 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.47 per share.
CenterPoint Energy Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||